SUMMIT, N.J., Jan 19, 2010 (BUSINESS WIRE) -- Celgene Corporation (NASDAQ: CELG) senior management will host a
conference call and live audio webcast on Thursday, January 28, 2010 at
9 a.m. ET to discuss the company's fourth quarter and full-year 2009
financial and operational results. The webcast will be available in the
investor relations section of the company's Web site at www.celgene.com.
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in the
discovery, development and commercialization of novel therapies for the
treatment of cancer and inflammatory diseases through gene and protein
regulation. For more information, please visit the company's Web site at www.celgene.com.
This release contains certain forward-looking statements which
involve known and unknown risks, delays, uncertainties and other factors
not under the Company's control. The Company's actual results,
performance, or achievements could be materially different from those
projected by these forward-looking statements.The factors that
could cause actual results, performance, or achievements to differ from
the forward-looking statements are discussed in the Company's filings
with the Securities and Exchange Commission, such as the Company's Form
10-K, 10-Q and 8-K reports.Given these risks and uncertainties,
you are cautioned not to place undue reliance on the forward-looking
statements.
SOURCE: Celgene Corporation
Celgene Corporation
David W. Gryska, 908-673-9059
Senior Vice President and Chief Financial Officer
or
Celgene Corporation
Timothy J. Smith, 908-673-9951
Director, Investor Relations
